(Q43211428)

16 November 2017

The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization (English)

1 reference

16 November 2017

3

1 reference

16 November 2017

4

1 reference

16 November 2017

14

1 reference

16 November 2017

Mariantonietta Capristo

Mariantonietta Capristo

6

0 references

Michela Rugolo

Michela Rugolo

17

0 references

Valerio Carelli

Valerio Carelli

15

0 references

Giovanni Tallini

Giovanni Tallini

13

0 references

author name string

Anna Maria Porcelli

1

1 reference

16 November 2017

Anna Ghelli

2

1 reference

16 November 2017

Giovanna Cenacchi

5

1 reference

16 November 2017

Lucia Fiammetta Pennisi

7

1 reference

16 November 2017

Isabella Morra

8

1 reference

16 November 2017

Enrica Ciccarelli

9

1 reference

16 November 2017

Antonio Melcarne

10

1 reference

16 November 2017

Anna Bartoletti-Stella

11

1 reference

16 November 2017

Nunzio Salfi

12

1 reference

16 November 2017

Marcella Attimonelli

16

1 reference

16 November 2017

Giovanni Romeo

18

1 reference

16 November 2017

Giuseppe Gasparre

19

1 reference

16 November 2017

22 December 2009

1 reference

16 November 2017

Human Molecular Genetics

1 reference

16 November 2017

19

1 reference

16 November 2017

6

1 reference

16 November 2017

1019-1032

1 reference

Mitochondrial disorders in the nervous system

16 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Lack of complex I is associated with oncocytic thyroid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Mitochondrial tumour suppressors: a genetic and biochemical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Activation of the HIF pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Somatic mutations of the mitochondrial genome in human colorectal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Mitochondrial DNA mutations in human colonic crypt stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Twinkle and POLG defects enhance age-dependent accumulation of mutations in the control region of mtDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

A late-onset mitochondrial myopathy is associated with a novel mitochondrial DNA (mtDNA) point mutation in the tRNA(Trp) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Mitochondrial mutations in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

HmtDB, a human mitochondrial genomic resource based on variability studies supporting population genetics and biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Mitochondrial DNA haplogroup T is associated with coronary artery disease and diabetic retinopathy: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Mutations of the mitochondrial ND1 gene as a cause of MELAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Homoplasmic MELAS A3243G mtDNA mutation in a colon cancer sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Prolyl hydroxylases as regulators of cell metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Mitochondrial dysfunction as a cause of optic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Mitochondria and cellular oxygen sensing in the HIF pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Mitochondrial complex I is deficient in renal oncocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

21 January 2018

Mitochondria and cancer

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Energy metabolism in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Metabolic enzymes as oncogenes or tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

mtDNA tree Build 17 (18 Feb 2016)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

The antioxidant function of Bcl-2 preserves cytoskeletal stability of cells with defective respiratory complex I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Respiratory complex I dysfunction due to mitochondrial DNA mutations shifts the voltage threshold for opening of the permeability transition pore toward resting levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

Human mtDNA site-specific variability values can act as haplogroup markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP566

21 January 2018

Identifiers

DOI

10.1093/HMG/DDP566

1 reference

16 November 2017

1 reference